Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Harvard Business School
Express Scripts
Baxter
Colorcon

Last Updated: February 17, 2020

DrugPatentWatch Database Preview

Interferon alfa-2b - Biologic Drug Details


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for interferon alfa-2b

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Centre Georges Francois LeclercPhase 2
Assiut UniversityPhase 1
Jonsson Comprehensive Cancer CenterPhase 1

See all interferon alfa-2b clinical trials

Recent Litigation for interferon alfa-2b

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Bay State Milling Company v. Arcadia Biosciences, Inc.2019-04-01
Novartis Vaccines and Diagnostics, Inc. v. Regeneron Pharmaceuticals, Inc.2018-03-19
Boston Heart Diagnostics Corporation v. MD Labs, Inc.2018-01-05

See all interferon alfa-2b litigation

PTAB Litigation
PetitionerDate
Regeneron Pharmaceuticals, Inc.2019-09-20
Regeneron Pharmaceuticals, Inc.2019-05-14
Baylor College of Medicine2018-04-18

See all interferon alfa-2b litigation

Pharmacology for interferon alfa-2b

Company Disclosures: US Patents for interferon alfa-2b

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Biogen N.V. (Curacao, AN) 2002-07-23 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2014-10-11 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2020-08-26 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for interferon alfa-2b

These patents were identified by searching patent claims

Supplementary Protection Certificates for interferon alfa-2b

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB03/013 United Kingdom   Start Trial PRODUCT NAME: MOROCTOCOG ALFA AS PRESENT IN THE EMEA APPROVED PRODUCT REFACTO, IN ALL FORMS SUBJECT TO THE BASIC PATENT; REGISTERED: UK EU/1/99/103/001 19990413; UK EU/1/99/103/002 19990413; UK EU/1/99/103/003 19990413
015 Luxembourg   Start Trial
/2017 Austria   Start Trial PRODUCT NAME: NUSINERSEN UND DESSEN SALZE; REGISTRATION NO/DATE: EU/1/17/1188 MITTEILUNG 20170601
371 Luxembourg   Start Trial 91371, EXPIRES: 20150319
2017 00054 Denmark   Start Trial PRODUCT NAME: NUSINERSEN ELLER SALTE DERAF; REG. NO/DATE: EU/1/17/1188 20170601
2017037,C2548560 Lithuania   Start Trial PRODUCT NAME: NUSINERSENAS ARBA JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1188/001 20170530
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Dow
Express Scripts
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.